新規登録 | ログイン | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

pjasper Gazdar [8 articles]

最近 pjasper さんのライブラリに追加された論文の中から 著者が Gazdar. であるものをリストアップしています. You can also see everyone's Gazdar.
  • Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
    Ann Oncol, Vol. 18, No. 4. (April 2007), pp. 752-760.
    posted to amplification egfr inhibitor iressa nsclc by pjasper on 2007-05-08 18:46:53 as **
  • Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Clin Cancer Res, Vol. 12, No. 23. (1 December 2006), pp. 7117-7125.
    by BA Helfrich, D Raben, M Varella-Garcia, D Gustafson, DC Chan, L Bemis, C Coldren, A Barón, C Zeng, WA Franklin, FR Hirsch, A Gazdar, J Minna, PA Bunn
    posted to akt egfr genomics iressa mutation nsclc by pjasper on 2007-04-26 17:27:15 as **
  • HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.
    Cancer Cell, Vol. 10, No. 1. (July 2006), pp. 25-38.
    by SE Wang, A Narasanna, M Perez-Torres, B Xiang, FY Wu, S Yang, G Carpenter, AF Gazdar, SK Muthuswamy, CL Arteaga
    posted to activation erbb2 inhibitor mutation resistance by pjasper on 2007-04-25 21:37:42 as **
  • Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
    Cancer Cell, Vol. 10, No. 1. (July 2006), pp. 39-50.
    by BB Zhou, M Peyton, B He, C Liu, L Girard, E Caudler, Y Lo, F Baribaud, I Mikami, N Reguart, G Yang, Y Li, W Yao, K Vaddi, AF Gazdar, SM Friedman, DM Jablons, RC Newton, JS Fridman, JD Minna, PA Scherle
    posted to adam erbb3 inhibitor nsclc by pjasper on 2007-04-25 21:37:16 as *****
  • Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
    Cancer Res, Vol. 66, No. 2. (15 January 2006), pp. 944-950.
    by SE Witta, RM Gemmill, FR Hirsch, CD Coldren, K Hedman, L Ravdel, B Helfrich, R Dziadziuszko, DC Chan, M Sugita, Z Chan, A Baron, W Franklin, HA Drabkin, L Girard, AF Gazdar, JD Minna, PA Bunn
    posted to e-cadhering iressa nsclc by pjasper on 2007-04-25 16:19:49 as ** along with 1 person MllePapillon
  • Inhibition of EGFR signaling: all mutations are not created equal.
    PLoS Med, Vol. 2, No. 11. (November 2005)
    by AF Gazdar, JD Minna
    posted to inhibitor mutation by pjasper on 2007-04-19 19:13:33 as **
  • Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers.
    Int J Cancer, Vol. 118, No. 2. (15 January 2006), pp. 257-262.
    posted to mutation nsclc review by pjasper on 2007-04-19 19:04:08 as **
  • Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.
    J Clin Oncol, Vol. 23, No. 22. (1 August 2005), pp. 5007-5018.
    posted to amplification erbb2 iressa nsclc by pjasper on 2007-04-18 20:38:35 as ***
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/user/pjasper/author/Gazdar

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.